相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi et al.
NATURE COMMUNICATIONS (2020)
Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities
Evangelia Theochari et al.
EPILEPSY & BEHAVIOR (2019)
Synaptic vesicle protein 2: A multi-faceted regulator of secretion
Kristine Ciruelas et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Brivaracetam efficacy and safety in focal epilepsy
Yamane Makke et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study
Manuel Toledo et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability
Eng Chuan Foo et al.
EPILEPSY & BEHAVIOR (2019)
BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
Vicente Villanueva et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model
Nathalie T. Sanon et al.
EPILEPSY & BEHAVIOR (2018)
Cognitive and fatigue side effects of anti-epileptic drugs: an analysis of phase III add-on trials
Rani A. Sarkis et al.
JOURNAL OF NEUROLOGY (2018)
Brivaracetam in the Treatment of Patients with epilepsy-First clinical experiences
Felix Zahnert et al.
FRONTIERS IN NEUROLOGY (2018)
Short-term and longer-term effects of brivaracetam on cognition and behavior in a naturalistic clinical setting-Preliminary data
Juri-Alexander Witt et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis
Martin Hirsch et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
Cerine C. Hansen et al.
BEHAVIOURAL NEUROLOGY (2018)
Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents
Susanne Schubert-Bast et al.
EPILEPSY & BEHAVIOR (2018)
Anger Assessment in Patients Treated With Brivaracetam
Gemma Ortega et al.
CLINICAL NEUROPHARMACOLOGY (2018)
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
Isabel Steinig et al.
EPILEPSIA (2017)
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
Baibing Chen et al.
EPILEPSY & BEHAVIOR (2017)
The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy
Emilio Russo et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
How can we overcome neuropsychological adverse effects of antiepileptic drugs?
Juri-Alexander Witt et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
The adverse event profile of brivaracetam: A meta-analysis of randomized controlled trials
Zhu Li-na et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Loescher et al.
CNS DRUGS (2016)
Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
Manuel Toledo et al.
EPILEPSIA (2016)
Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
Henrik Klitgaard et al.
EPILEPSIA (2016)
Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study
Hsiu-Fang Chen et al.
EPILEPSY & BEHAVIOR (2016)
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Elinor Ben-Menachem et al.
NEUROLOGY (2016)
Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison
Zhang Lin et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam
Carola Stockburger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
Stephen L. Yates et al.
EPILEPSY & BEHAVIOR (2015)
Memory in children with epilepsy: A systematic review
Leanne Menlove et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2015)
Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice
Jian-Quan Shi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Which drug-induced side effects would be tolerated in the prospect of seizure control?
Juri-Alexander Witt et al.
EPILEPSY & BEHAVIOR (2013)
Antiepileptic drug effects on mood and behavior: Molecular targets
Piero Perucca et al.
EPILEPSY & BEHAVIOR (2013)
Monitoring the cognitive effects of antiepileptic pharmacotherapy - approaching the individual patient
Juri-Alexander Witt et al.
EPILEPSY & BEHAVIOR (2013)
Effects of Levetiracetam Monotherapy on the Cognitive Function of Epilepsy Patients
Dae Lim Koo et al.
EUROPEAN NEUROLOGY (2013)
Molecular mechanisms of antiseizure drug activity at GABAA receptors
L. John Greenfield
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?
Jacqueline A. French et al.
EPILEPSY CURRENTS (2012)
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam
Kimford J. Meador et al.
EPILEPSIA (2011)
Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review
Rod S. Taylor et al.
EPILEPSIA (2011)
The cognitive impact of antiepileptic drugs
Clare M. Eddy et al.
Therapeutic Advances in Neurological Disorders (2011)
Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats
E. R. Detrait et al.
EPILEPSY RESEARCH (2010)
Antiepileptic Drug-Induced Cognitive Adverse Effects Potential Mechanisms and Contributing Factors
Marco Mula et al.
CNS DRUGS (2009)
Neuropsychological predictors of quality of life in focal epilepsy
Rute F. Meneses et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
The effects of levetiracetam on cognition: A non-interventional surveillance study
Christoph Helmstaedter et al.
EPILEPSY & BEHAVIOR (2008)
Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison
H. P. R. Bootsma et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy
D. Weintraub et al.
EPILEPSY & BEHAVIOR (2007)
Effects of antiepileptic drugs on mood and behavior
Bettina Schmitz
EPILEPSIA (2006)
Effect of levetiracetam on epilepsy-related quality of life
JA Cramer et al.
EPILEPSIA (2000)
分享论文
